President & Immunovant CEO
Fri, Nov 7, 2025
Nov 7
200,000 shares @ $20.22
Decreased holdings by -3.20%
26th largest trade (out of 285)
Large Trade
Trade made by an officer
10b5-1 scheduled trade
36% win rate · -5.5% median edge vs SPY (76 trades, 90-day)
Price 68% above 200-day moving average